Longitudinal cognitive decline and TMEM106B genotype

Takeaway

  • TMEM106B is a genetic modifier of cognitive decline for those with Parkinson’s disease (PD).

Why this matters

  • This study indicates the lysosomal protein TMEM106B as a potential therapeutic target for cognitive symptoms in PD.